Dušan Spasić
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dušan Spasić has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Milica Bajcetic
Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
4 shared publications - Čedo Miljević
Institute of Mental Health, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
4 shared publications - Aleksandra Nikolić-Kokić
Department of Physiology, Institute for Biological Research “Sinisa Stankovic”—National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia
3 shared publications - Marija Kukuric
Department of Emergency Radiology, University Clinical Center of Serbia, 11000 Belgrade, Serbia
3 shared publications - Milan Nikolić
Department of Biochemistry, Faculty of Chemistry, University of Belgrade, 11000 Belgrade, Serbia
3 shared publications - Milica Radibratovic
Department of Chemistry, Institute for Chemistry, Technology and Metallurgy, National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia
2 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9771
Frequent PRAME Expression in Ameloblastoma: Immunohistochemical Profiling, Clinicopathologic Correlations, and Interobserver Reproducibility in a 37-Case Cohort
Ameloblastoma is a histologically benign odontogenic epithelial tumor with locally destructive growth and a clinically relevant risk of recurrence. Established molecular research has been largely focused on MAPK-pathway alterations, whereas markers capturing other dimensions of tumor biology remain limited. Preferentially expressed antigen in melanoma (PRAME) is a tumor-associated antigen implicated in retinoic-acid receptor signaling, altered differentiation, and antitumor immune recognition, but dedicated data in ameloblastoma remain limited. In this retrospective cohort, 37 histologically confirmed ameloblastomas were evaluated immunohistochemically for PRAME on tissue microarray sections by two independent pathologists. A four-tier extent score (0, 1+, 2+, 3+) and a four-tier intensity score (absent, weak, moderate, strong) were recorded. PRAME positivity was defined as nuclear staining in ≥25% of tumor cells for exploratory association analyses. Clinicopathologic variables included age, sex, anatomic site, side, mandibular subsite, histologic type, surgical approach, recurrence, and follow-up. Interobserver reproducibility was assessed using percentage agreement and Cohen’s κ statistics. Holm adjustment was applied as a post hoc sensitivity analysis across eight exploratory clinicopathological comparisons. PRAME was positive in 30 of 37 tumors (81.1%; exact 95% CI 64.8–92.0). Twenty-nine tumors (78.4%) received a 3+ extent score from both observers, seven (18.9%) were negative, and the remaining tumor was scored 1+ by one observer and 2+ by the other. Extent scoring agreed in 36 of 37 cases (97.3% agreement; Cohen kappa = 0.923). Intensity scoring agreed in 35 of 37 cases (94.6%); unweighted kappa was 0.905, with linear and quadratic weighted kappa values of 0.927 and 0.949. PRAME positivity was more frequent in women than in men (95.2% vs. 62.5%; unadjusted two-sided Fisher exact p = 0.029; Holm-adjusted p = 0.230). All 11 patients with documented recurrence had PRAME-positive tumors, compared with 19 of 26 patients without documented recurrence (unadjusted p = 0.080). PRAME positivity was also more frequent among conservatively than radically treated patients (91.7% vs. 61.5%; unadjusted p = 0.072). None of the eight clinicopathological comparisons met the 0.05 threshold after Holm adjustment. PRAME is frequently and extensively expressed in ameloblastoma and can be assessed with excellent interobserver reproducibility. The recurrence and treatment patterns are hypothesis-generating, but the small cohort, sparse PRAME-negative subgroup, and treatment imbalance preclude claims of independent prognostic value. Larger multicenter studies with standardized scoring, molecular validation, and time-to-event analysis are warranted.
- 30 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9771
Open AccessFrequent PRAME Expression in Ameloblastoma: Immunohistochemical Profiling, Clinicopathologic Correlations, and Interobserver Reproducibility in a 37-Case Cohort
Ameloblastoma is a histologically benign odontogenic epithelial tumor with locally destructive growth and a clinically relevant risk of recurrence. Established molecular research has been largely focused on MAPK-pathway alterations, whereas markers capturing other dimensions of tumor biology remain limited. Preferentially expressed antigen in melanoma (PRAME) is a tumor-associated antigen implicated in retinoic-acid receptor signaling, altered differentiation, and antitumor immune recognition, but dedicated data in ameloblastoma remain limited. In this retrospective cohort, 37 histologically confirmed ameloblastomas were evaluated immunohistochemically for PRAME on tissue microarray sections by two independent pathologists. A four-tier extent score (0, 1+, 2+, 3+) and a four-tier intensity score (absent, weak, moderate, strong) were recorded. PRAME positivity was defined as nuclear staining in ≥25% of tumor cells for exploratory association analyses. Clinicopathologic variables included age, sex, anatomic site, side, mandibular subsite, histologic type, surgical approach, recurrence, and follow-up. Interobserver reproducibility was assessed using percentage agreement and Cohen’s κ statistics. Holm adjustment was applied as a post hoc sensitivity analysis across eight exploratory clinicopathological comparisons. PRAME was positive in 30 of 37 tumors (81.1%; exact 95% CI 64.8–92.0). Twenty-nine tumors (78.4%) received a 3+ extent score from both observers, seven (18.9%) were negative, and the remaining tumor was scored 1+ by one observer and 2+ by the other. Extent scoring agreed in 36 of 37 cases (97.3% agreement; Cohen kappa = 0.923). Intensity scoring agreed in 35 of 37 cases (94.6%); unweighted kappa was 0.905, with linear and quadratic weighted kappa values of 0.927 and 0.949. PRAME positivity was more frequent in women than in men (95.2% vs. 62.5%; unadjusted two-sided Fisher exact p = 0.029; Holm-adjusted p = 0.230). All 11 patients with documented recurrence had PRAME-positive tumors, compared with 19 of 26 patients without documented recurrence (unadjusted p = 0.080). PRAME positivity was also more frequent among conservatively than radically treated patients (91.7% vs. 61.5%; unadjusted p = 0.072). None of the eight clinicopathological comparisons met the 0.05 threshold after Holm adjustment. PRAME is frequently and extensively expressed in ameloblastoma and can be assessed with excellent interobserver reproducibility. The recurrence and treatment patterns are hypothesis-generating, but the small cohort, sparse PRAME-negative subgroup, and treatment imbalance preclude claims of independent prognostic value. Larger multicenter studies with standardized scoring, molecular validation, and time-to-event analysis are warranted.
- Open Access
- 20 August 2026
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 22 (4) , 2231-2249
Metabolic alterations and redox homeostasis in ferroptosis: emerging mechanisms and therapeutic implications
Ferroptosis is a programmed cell death characterized by excessive, iron-dependent accumulation of membrane lipid peroxides due to insufficient glutathione-dependent antioxidant defense. It is influenced by the metabolism of amino acids, lipids, and iron, and occurs in conditions of decreased glutathione peroxidase 4 (GPX4) activity. The increased polyunsaturated fatty acid (PUFA) content in membrane phospholipids is associated with cellular hypersusceptibility to ferroptosis. In contrast, incorporation of monounsaturated fatty acids may protect cells against ferroptotic cell death. Cellular sensitivity to ferroptosis is additionally influenced by glutamine catabolism and the xc–system-mediated import of cystine, which modulate glutathione production, and by elevated iron levels, which lead to the buildup of reactive oxygen species (ROS) that attack membrane-localized PUFAs. This review focuses on recent findings of perturbed metabolic processes in cancer that create a high iron demand and an altered lipid composition, thereby predisposing cells to ferroptosis. We analyze the therapeutic potential of pharmacological agents that can selectively trigger ferroptosis in tumor cells.
- 20 August 2026
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 22 (4) , 2231-2249
Open AccessMetabolic alterations and redox homeostasis in ferroptosis: emerging mechanisms and therapeutic implications
Ferroptosis is a programmed cell death characterized by excessive, iron-dependent accumulation of membrane lipid peroxides due to insufficient glutathione-dependent antioxidant defense. It is influenced by the metabolism of amino acids, lipids, and iron, and occurs in conditions of decreased glutathione peroxidase 4 (GPX4) activity. The increased polyunsaturated fatty acid (PUFA) content in membrane phospholipids is associated with cellular hypersusceptibility to ferroptosis. In contrast, incorporation of monounsaturated fatty acids may protect cells against ferroptotic cell death. Cellular sensitivity to ferroptosis is additionally influenced by glutamine catabolism and the xc–system-mediated import of cystine, which modulate glutathione production, and by elevated iron levels, which lead to the buildup of reactive oxygen species (ROS) that attack membrane-localized PUFAs. This review focuses on recent findings of perturbed metabolic processes in cancer that create a high iron demand and an altered lipid composition, thereby predisposing cells to ferroptosis. We analyze the therapeutic potential of pharmacological agents that can selectively trigger ferroptosis in tumor cells.
- Open Access
- 8 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7105
Redox Homeostasis and Oxidative Stress in Schizophrenia: Glutathione–NMDA–Neuroimmune Convergence and a Hypothesis-Generating Iron–Lipid Redox Extension
Schizophrenia is a heterogeneous neurodevelopmental disorder in which genetic liability, developmental exposures, illness stage, treatment, and metabolic or inflammatory comorbidity may shape redox biology. This narrative review evaluates the human and mechanistic evidence for impaired redox adaptation as a convergence mechanism linking glutathione (GSH) regulation, N-methyl-D-aspartate receptor hypofunction, parvalbumin-interneuron and perineuronal-net vulnerability, mitochondrial–glial dysfunction, and neuroimmune signalling. The findings do not support a uniform oxidative abnormality across all patients or compartments: the peripheral biomarkers are heterogeneous, the group-level brain GSH magnetic resonance spectroscopy findings are largely null, and treatment-related changes vary by marker and illness phase. Beyond the established GSH–NMDA–redox–immune models, we integrate iron–lipid redox regulation as a conditional, hypothesis-generating extension and apply a deliberately conservative evidence hierarchy. Human studies more often report a lower peripheral iron and reduced or redistributed brain iron than a uniform iron excess; the plasma signals for predominantly intracellular proteins remain analytically unvalidated, and ferroptotic neuronal death has not been demonstrated. Longitudinal, sex-aware, multi-compartment, and challenge-based studies are needed to define meaningful redox subgroups; no redox- or ferroptosis-related biomarker is currently validated to guide treatment selection.
- 8 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7105
Open AccessRedox Homeostasis and Oxidative Stress in Schizophrenia: Glutathione–NMDA–Neuroimmune Convergence and a Hypothesis-Generating Iron–Lipid Redox Extension
Schizophrenia is a heterogeneous neurodevelopmental disorder in which genetic liability, developmental exposures, illness stage, treatment, and metabolic or inflammatory comorbidity may shape redox biology. This narrative review evaluates the human and mechanistic evidence for impaired redox adaptation as a convergence mechanism linking glutathione (GSH) regulation, N-methyl-D-aspartate receptor hypofunction, parvalbumin-interneuron and perineuronal-net vulnerability, mitochondrial–glial dysfunction, and neuroimmune signalling. The findings do not support a uniform oxidative abnormality across all patients or compartments: the peripheral biomarkers are heterogeneous, the group-level brain GSH magnetic resonance spectroscopy findings are largely null, and treatment-related changes vary by marker and illness phase. Beyond the established GSH–NMDA–redox–immune models, we integrate iron–lipid redox regulation as a conditional, hypothesis-generating extension and apply a deliberately conservative evidence hierarchy. Human studies more often report a lower peripheral iron and reduced or redistributed brain iron than a uniform iron excess; the plasma signals for predominantly intracellular proteins remain analytically unvalidated, and ferroptotic neuronal death has not been demonstrated. Longitudinal, sex-aware, multi-compartment, and challenge-based studies are needed to define meaningful redox subgroups; no redox- or ferroptosis-related biomarker is currently validated to guide treatment selection.
- Open Access
- 16 July 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (7) , 694
Antibiotic Resistance Profiles of Invasive Bacterial Isolates from Hospitalized Pediatric Patients in Serbia: A Multicenter Surveillance Study, 2020–2024
Background: Antimicrobial resistance (AMR) threatens empirical therapy for invasive pediatric infections, but contemporary data from Serbia and the Western Balkans remain limited for blood and cerebrospinal fluid isolates. Methods: We performed a retrospective CAESAR-linked multicenter microbiological surveillance analysis of first eligible invasive bacterial isolates from hospitalized children in Serbia from 1 January 2020 to 31 December 2024. Organism distribution, ESBL production, carbapenemase marker results, and selected resistance outcomes were analyzed descriptively and with temporal trend and multivariable models. Results: Among 907 isolates, 879 (96.9%) were recovered from blood and 28 (3.1%) from cerebrospinal fluid; neonates and infants accounted for 57.9% of isolates. K. pneumoniae was the predominant organism (318/907, 35.1%), followed by E. coli (172/907, 19.0%), S. aureus (137/907, 15.1%), and Acinetobacter spp. (96/907, 10.6%). Among K. pneumoniae and E. coli isolates with available ESBL results, ESBL production was frequent, whereas carbapenemase testing was restricted to a selected subset and the carbapenemase type was not recorded in the national surveillance extract. In K. pneumoniae, meropenem resistance increased from 19.7% in 2020 to 48.6% in 2024, and later study years remained independently associated with meropenem resistance after adjustment. Conclusions: This microbiological surveillance study identifies K. pneumoniae predominance, neonatal concentration, frequent ESBL production, and a rising carbapenem-resistance signal as the principal findings among invasive pediatric isolates in Serbia. Resistance estimates, particularly carbapenemase production, should be interpreted as surveillance indicators rather than clinical prevalence estimates. These data support strengthened pediatric invasive-isolate surveillance, center- and age-specific antibiograms, molecular characterization, and coordinated antimicrobial stewardship and infection prevention and control efforts within the wider European AMR context.
- 16 July 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (7) , 694
Open AccessAntibiotic Resistance Profiles of Invasive Bacterial Isolates from Hospitalized Pediatric Patients in Serbia: A Multicenter Surveillance Study, 2020–2024
Background: Antimicrobial resistance (AMR) threatens empirical therapy for invasive pediatric infections, but contemporary data from Serbia and the Western Balkans remain limited for blood and cerebrospinal fluid isolates. Methods: We performed a retrospective CAESAR-linked multicenter microbiological surveillance analysis of first eligible invasive bacterial isolates from hospitalized children in Serbia from 1 January 2020 to 31 December 2024. Organism distribution, ESBL production, carbapenemase marker results, and selected resistance outcomes were analyzed descriptively and with temporal trend and multivariable models. Results: Among 907 isolates, 879 (96.9%) were recovered from blood and 28 (3.1%) from cerebrospinal fluid; neonates and infants accounted for 57.9% of isolates. K. pneumoniae was the predominant organism (318/907, 35.1%), followed by E. coli (172/907, 19.0%), S. aureus (137/907, 15.1%), and Acinetobacter spp. (96/907, 10.6%). Among K. pneumoniae and E. coli isolates with available ESBL results, ESBL production was frequent, whereas carbapenemase testing was restricted to a selected subset and the carbapenemase type was not recorded in the national surveillance extract. In K. pneumoniae, meropenem resistance increased from 19.7% in 2020 to 48.6% in 2024, and later study years remained independently associated with meropenem resistance after adjustment. Conclusions: This microbiological surveillance study identifies K. pneumoniae predominance, neonatal concentration, frequent ESBL production, and a rising carbapenem-resistance signal as the principal findings among invasive pediatric isolates in Serbia. Resistance estimates, particularly carbapenemase production, should be interpreted as surveillance indicators rather than clinical prevalence estimates. These data support strengthened pediatric invasive-isolate surveillance, center- and age-specific antibiograms, molecular characterization, and coordinated antimicrobial stewardship and infection prevention and control efforts within the wider European AMR context.
- Open Access
- 22 May 2026
- Published by Frontiers Media SA in Frontiers in Artificial Intelligence
- Vol. 9, 1808422
MRI-based morphometric analysis of the patellofemoral joint: diagnostic modeling of knee pathologies in adolescents
Introduction: To evaluate whether routinely measured MRI-based patellofemoral joint morphometric parameters can support diagnostic modeling of selected adolescent knee pathologies and to compare a conventional multivariable logistic regression baseline with machine-learning approaches. Methods: This retrospective single-center pilot diganostic modeling study included 168 adolescents (97 girls, 71 boys, mean age 15.5 ± 1.7 years) who underwent knee MRI between January 2018 and December 2024 because of anterior knee pain or suspected patellofemoral structural abnormality. Thirteen patellofemoral morphometric parameters were measured by two radiologists. Three binary MRI endpoints were modeled: composite chondromalacia, a composite endpoint of ACL injury or patellar bone bruise, and patellar retinacular lesion. Baseline multivariable logistic regression was compared with machine-learning approaches using chronological training, validation, and test splits. Additional gradient-boosting comparators were evaluated, and uncertainty was quantified using bootstrap confidence intervals on the independent test set. Results: In multivariable logistic regression, no individual continuous morphometric predictor reached statistical significance for any endpoint. After correction of the model-selection procedure, predictive performance proved endpoint-specific rather than uniformly strong. For composite chondromalacia, discrimination remained weak. For the ACL injury/patellar bone bruise composite, machine-learning models showed only modest improvement in point estimates over logistic regression, but confidence intervals for differences crossed zero. The strongest reproducible signal was observed for patellar retinacular lesions. After correction of model selection and bootstrap-based uncertainty estimation, a morphometric-only CatBoost model achieved an AUC of 0.85 (95% CI 0.68–0.97) and balanced accuracy of 0.79 (95% CI 0.61–0.94), while a morphometric-only LightGBM model achieved an AUC of 0.84 (95% CI 0.64–0.97) and balanced accuracy of 0.76 (95% CI 0.59–0.88). Discussion: In adolescents, routine patellofemoral morphometrics do not provide uniformly strong diagnostic discrimination across all MRI-defined knee pathologies studied here. Their most convincing predictive value was observed for patellar retinacular lesions, whereas performance for composite chondromalacia and the ACL injury/patellar bone bruise composite remained limited. These findings support a narrower interpretation of clinical utility and justify further validation in larger external cohorts.
- 22 May 2026
- Published by Frontiers Media SA in Frontiers in Artificial Intelligence
- Vol. 9, 1808422
Open AccessMRI-based morphometric analysis of the patellofemoral joint: diagnostic modeling of knee pathologies in adolescents
Introduction: To evaluate whether routinely measured MRI-based patellofemoral joint morphometric parameters can support diagnostic modeling of selected adolescent knee pathologies and to compare a conventional multivariable logistic regression baseline with machine-learning approaches. Methods: This retrospective single-center pilot diganostic modeling study included 168 adolescents (97 girls, 71 boys, mean age 15.5 ± 1.7 years) who underwent knee MRI between January 2018 and December 2024 because of anterior knee pain or suspected patellofemoral structural abnormality. Thirteen patellofemoral morphometric parameters were measured by two radiologists. Three binary MRI endpoints were modeled: composite chondromalacia, a composite endpoint of ACL injury or patellar bone bruise, and patellar retinacular lesion. Baseline multivariable logistic regression was compared with machine-learning approaches using chronological training, validation, and test splits. Additional gradient-boosting comparators were evaluated, and uncertainty was quantified using bootstrap confidence intervals on the independent test set. Results: In multivariable logistic regression, no individual continuous morphometric predictor reached statistical significance for any endpoint. After correction of the model-selection procedure, predictive performance proved endpoint-specific rather than uniformly strong. For composite chondromalacia, discrimination remained weak. For the ACL injury/patellar bone bruise composite, machine-learning models showed only modest improvement in point estimates over logistic regression, but confidence intervals for differences crossed zero. The strongest reproducible signal was observed for patellar retinacular lesions. After correction of model selection and bootstrap-based uncertainty estimation, a morphometric-only CatBoost model achieved an AUC of 0.85 (95% CI 0.68–0.97) and balanced accuracy of 0.79 (95% CI 0.61–0.94), while a morphometric-only LightGBM model achieved an AUC of 0.84 (95% CI 0.64–0.97) and balanced accuracy of 0.76 (95% CI 0.59–0.88). Discussion: In adolescents, routine patellofemoral morphometrics do not provide uniformly strong diagnostic discrimination across all MRI-defined knee pathologies studied here. Their most convincing predictive value was observed for patellar retinacular lesions, whereas performance for composite chondromalacia and the ACL injury/patellar bone bruise composite remained limited. These findings support a narrower interpretation of clinical utility and justify further validation in larger external cohorts.
- Open Access
- 20 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (10) , 4574
Impact of COVID-19 Booster Vaccination on Serum Redox Homeostasis
This study examined alterations in serum redox biomarkers before and one month after administration of the coronavirus disease 2019 (COVID-19) booster (third) doses across four vaccine regimens. A longitudinal cohort of 410 adults was analyzed following homologous Pfizer-BioNTech, Sinopharm [Vero Cell]-Inactivated, Sputnik V, or heterologous Sinopharm/Pfizer vaccination. Serum total proteins, albumin, total thiols, nitrites, ferric-reducing antioxidant power (FRAP), and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging activity were measured, with DPPH interpreted as an ex vivo surrogate of serum radical-scavenging capacity. Additional analyses included stratification by prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, multivariable regression, correlation analysis, effect-size estimation, and sensitivity testing. Booster vaccination was associated with modest but consistent decreases in DPPH activity, albumin, and total proteins, whereas FRAP, nitrite, and total thiol levels remained stable. This pattern supports a transient shift in antioxidant buffering capacity but, by itself, does not exclude oxidative stress, as direct oxidative damage markers were not assessed. The most pronounced changes were observed in Sinopharm-based regimens, particularly in the heterologous Sinopharm/Pfizer group. Prior SARS-CoV-2 infection did not materially alter the qualitative response pattern, whereas older age and comorbidities were associated with greater declines in DPPH activity and albumin. Overall, the findings indicate a modest, transient redox-associated response following booster-induced immune activation and suggest that host-related factors, such as age and comorbidity burden, may accentuate short-term changes in antioxidant buffering capacity.
- 20 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (10) , 4574
Open AccessImpact of COVID-19 Booster Vaccination on Serum Redox Homeostasis
This study examined alterations in serum redox biomarkers before and one month after administration of the coronavirus disease 2019 (COVID-19) booster (third) doses across four vaccine regimens. A longitudinal cohort of 410 adults was analyzed following homologous Pfizer-BioNTech, Sinopharm [Vero Cell]-Inactivated, Sputnik V, or heterologous Sinopharm/Pfizer vaccination. Serum total proteins, albumin, total thiols, nitrites, ferric-reducing antioxidant power (FRAP), and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging activity were measured, with DPPH interpreted as an ex vivo surrogate of serum radical-scavenging capacity. Additional analyses included stratification by prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, multivariable regression, correlation analysis, effect-size estimation, and sensitivity testing. Booster vaccination was associated with modest but consistent decreases in DPPH activity, albumin, and total proteins, whereas FRAP, nitrite, and total thiol levels remained stable. This pattern supports a transient shift in antioxidant buffering capacity but, by itself, does not exclude oxidative stress, as direct oxidative damage markers were not assessed. The most pronounced changes were observed in Sinopharm-based regimens, particularly in the heterologous Sinopharm/Pfizer group. Prior SARS-CoV-2 infection did not materially alter the qualitative response pattern, whereas older age and comorbidities were associated with greater declines in DPPH activity and albumin. Overall, the findings indicate a modest, transient redox-associated response following booster-induced immune activation and suggest that host-related factors, such as age and comorbidity burden, may accentuate short-term changes in antioxidant buffering capacity.
- Open Access
Catalase Specifically Binds Antipsychotic Clozapine: Experimental and In Silico Insights into Interactions, Complex Stability, and Dose-Dependent Enzyme Activity Modulation
Oxidative stress is intrinsically linked to mental disorders, involving an imbalance between reactive species and antioxidant defenses, where catalase is an essential, ubiquitous antioxidant enzyme. The pleiotropic effects of antipsychotic drugs, used for schizophrenia and mood disorders, are not fully elucidated at the molecular level. This study characterized the binding of a highly effective but potentially dangerous antipsychotic, clozapine (CLZ), to commercial bovine liver catalase (BLC). Using various spectroscopic methods under simulated physiological conditions, we found a moderate binding affinity of CLZ for BLC (Ka = 1.4 × 10−5 M−1), subtly influencing the protein’s secondary and tertiary structures and slightly increasing its thermal stability. CLZ efficiently protected BLC against free-radical-induced oxidation and preserved its catalytic activity for decomposing toxic hydrogen peroxide. The effect of CLZ on BLC antioxidant activity was dual: no significant effect at lower, physiologically relevant concentrations, but significant inhibition at saturating, toxic drug concentrations. Molecular docking and molecular dynamics results indicated the presence of two specific binding sites within BLC monomers, one located near its active site. In conclusion, our in vitro results indicate that CLZ’s specific binding to BLC can be both beneficial and potentially harmful, and that this effect is dose-dependent.
Open AccessCatalase Specifically Binds Antipsychotic Clozapine: Experimental and In Silico Insights into Interactions, Complex Stability, and Dose-Dependent Enzyme Activity Modulation
Oxidative stress is intrinsically linked to mental disorders, involving an imbalance between reactive species and antioxidant defenses, where catalase is an essential, ubiquitous antioxidant enzyme. The pleiotropic effects of antipsychotic drugs, used for schizophrenia and mood disorders, are not fully elucidated at the molecular level. This study characterized the binding of a highly effective but potentially dangerous antipsychotic, clozapine (CLZ), to commercial bovine liver catalase (BLC). Using various spectroscopic methods under simulated physiological conditions, we found a moderate binding affinity of CLZ for BLC (Ka = 1.4 × 10−5 M−1), subtly influencing the protein’s secondary and tertiary structures and slightly increasing its thermal stability. CLZ efficiently protected BLC against free-radical-induced oxidation and preserved its catalytic activity for decomposing toxic hydrogen peroxide. The effect of CLZ on BLC antioxidant activity was dual: no significant effect at lower, physiologically relevant concentrations, but significant inhibition at saturating, toxic drug concentrations. Molecular docking and molecular dynamics results indicated the presence of two specific binding sites within BLC monomers, one located near its active site. In conclusion, our in vitro results indicate that CLZ’s specific binding to BLC can be both beneficial and potentially harmful, and that this effect is dose-dependent.
- Open Access
Serious Adverse Drug Reactions Associated with Off-Label and Unlicensed Drug Use in Children: A 14-Year Analysis of VigiBase Reports from Serbia
Background/Objectives: Adverse drug reactions are associated with off-label (OL) and unlicensed (UL) drug use in children. Methods: We conducted a retrospective observational pharmacovigilance study based on individual case safety reports (ICSRs) and adverse drug reactions (ADRs) from VigiBase for patients aged 0–17 years to evaluate reporting patterns associated with off-label and unlicensed suspected drugs reported in Serbia. Results: Over 14 years, 2037 pediatric ICSRs comprising 4257 ADRs were reported. Infants (28 days–23 months) accounted for just over half of ICSRs, and systemic anti-infectives and vaccines dominated suspected drugs. Overall, 9.7% of ADRs were serious, including 12 fatal outcomes, with serious ADRs reported more often for non-vaccine than vaccine suspected drugs. Off-label and unlicensed suspected drug records accounted for 10.8% and 1.9% of suspected drug records, respectively, and had higher proportions of serious ADRs than on-label or licensed use (off-label 12.1% vs. on-label 9.4%, p = 0.04; unlicensed 22.9% vs. licensed 9.4%, p < 0.001). In the adjusted ICSR-level logistic regression, neonatal age was the strongest independent predictor of seriousness, with approximately threefold higher odds of a serious case compared with children (aOR 3.04, 95% CI 1.55–5.98). Conclusions: Although off-label and unlicensed drugs accounted for a minority of pediatric reports, they were associated with a higher proportion of serious reported ADRs, particularly in the neonatal period. These findings should be interpreted as pharmacovigilance reporting patterns rather than incidence-based estimates or proof of causality.
Open AccessSerious Adverse Drug Reactions Associated with Off-Label and Unlicensed Drug Use in Children: A 14-Year Analysis of VigiBase Reports from Serbia
Background/Objectives: Adverse drug reactions are associated with off-label (OL) and unlicensed (UL) drug use in children. Methods: We conducted a retrospective observational pharmacovigilance study based on individual case safety reports (ICSRs) and adverse drug reactions (ADRs) from VigiBase for patients aged 0–17 years to evaluate reporting patterns associated with off-label and unlicensed suspected drugs reported in Serbia. Results: Over 14 years, 2037 pediatric ICSRs comprising 4257 ADRs were reported. Infants (28 days–23 months) accounted for just over half of ICSRs, and systemic anti-infectives and vaccines dominated suspected drugs. Overall, 9.7% of ADRs were serious, including 12 fatal outcomes, with serious ADRs reported more often for non-vaccine than vaccine suspected drugs. Off-label and unlicensed suspected drug records accounted for 10.8% and 1.9% of suspected drug records, respectively, and had higher proportions of serious ADRs than on-label or licensed use (off-label 12.1% vs. on-label 9.4%, p = 0.04; unlicensed 22.9% vs. licensed 9.4%, p < 0.001). In the adjusted ICSR-level logistic regression, neonatal age was the strongest independent predictor of seriousness, with approximately threefold higher odds of a serious case compared with children (aOR 3.04, 95% CI 1.55–5.98). Conclusions: Although off-label and unlicensed drugs accounted for a minority of pediatric reports, they were associated with a higher proportion of serious reported ADRs, particularly in the neonatal period. These findings should be interpreted as pharmacovigilance reporting patterns rather than incidence-based estimates or proof of causality.
- Open Access
- 9 February 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1730266
Long-term public antibiotic awareness campaign significantly reduced inappropriate antibiotic use in pediatric primary care settings
Introduction: Serbia, like most countries in Southern Europe, has faced persistently high rates of antibiotic consumption. Previous analyses revealed that most antibiotics were prescribed inappropriately, mainly for influenza-like illnesses. Methods: The first short term media antibiotic awareness campaign (AAC) was held in 2011 and 2014 respectively. Shortly after, in November 2015, the Serbian Ministry of Health launched a nationwide public AAC. The campaign adapted the European Centre for Disease Prevention and Control (ECDC) and World Health Organization (WHO) communication platforms, methodological frameworks, and promotional materials under the motto “Careful with Antibiotics.” Results: In addition to 423 media features, the campaign encompassed professional education, as well as the development of national guidelines and regulations. Educational activities targeting the public and healthcare professionals (2,119 pediatricians, 428 nurses, and 6,083 pharmacists) were guided by prior analyses of pediatric antibiotic consumption. Over 6 years, 8,750 brochures, 5,500 posters, and more than 3,000 other educational materials were distributed to 158 primary-care centers, pharmacies and in public places nationwide. Long-term campaign interventions resulted in a 32.8% reduction in the number of systemic antibiotic prescriptions per 1,000 children between 2015 and 2021. The most pronounced declines were observed among younger children (2–23 months and 2–11 years respectively) aligning with the main target group of the educational efforts, which focused on young children, including preschool and early school-aged children, who had the highest baseline prescribing rates. Excluding the common cold, the significant decreases were recorded for pharyngitis, tonsillitis, otitis media, and bronchitis, conditions that previously accounted for most inappropriate antibiotic use. From 2011, Serbia’s maximum 61% reduction in pediatric antibiotic prescription rates ranks among the most pronounced in Europe. Despite a gradual shift toward broader-spectrum agents, the Access-group share remained around 60% throughout most of the observation period. Conclusion: Serbia’s long-term, multisectoral stewardship campaign achieved one of the largest and most sustained declines in pediatric antibiotic consumption across Europe.
- 9 February 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1730266
Open AccessLong-term public antibiotic awareness campaign significantly reduced inappropriate antibiotic use in pediatric primary care settings
Introduction: Serbia, like most countries in Southern Europe, has faced persistently high rates of antibiotic consumption. Previous analyses revealed that most antibiotics were prescribed inappropriately, mainly for influenza-like illnesses. Methods: The first short term media antibiotic awareness campaign (AAC) was held in 2011 and 2014 respectively. Shortly after, in November 2015, the Serbian Ministry of Health launched a nationwide public AAC. The campaign adapted the European Centre for Disease Prevention and Control (ECDC) and World Health Organization (WHO) communication platforms, methodological frameworks, and promotional materials under the motto “Careful with Antibiotics.” Results: In addition to 423 media features, the campaign encompassed professional education, as well as the development of national guidelines and regulations. Educational activities targeting the public and healthcare professionals (2,119 pediatricians, 428 nurses, and 6,083 pharmacists) were guided by prior analyses of pediatric antibiotic consumption. Over 6 years, 8,750 brochures, 5,500 posters, and more than 3,000 other educational materials were distributed to 158 primary-care centers, pharmacies and in public places nationwide. Long-term campaign interventions resulted in a 32.8% reduction in the number of systemic antibiotic prescriptions per 1,000 children between 2015 and 2021. The most pronounced declines were observed among younger children (2–23 months and 2–11 years respectively) aligning with the main target group of the educational efforts, which focused on young children, including preschool and early school-aged children, who had the highest baseline prescribing rates. Excluding the common cold, the significant decreases were recorded for pharyngitis, tonsillitis, otitis media, and bronchitis, conditions that previously accounted for most inappropriate antibiotic use. From 2011, Serbia’s maximum 61% reduction in pediatric antibiotic prescription rates ranks among the most pronounced in Europe. Despite a gradual shift toward broader-spectrum agents, the Access-group share remained around 60% throughout most of the observation period. Conclusion: Serbia’s long-term, multisectoral stewardship campaign achieved one of the largest and most sustained declines in pediatric antibiotic consumption across Europe.